To help address a devastating surge of COVID-19 cases in India, the Global Fund to Fight AIDS, Tuberculosis and Malaria is making $75 million in emergency funding available to the government of India and its partners.
As part of its emergency response to the pandemic, the Global Fund is fast-tracking an application to its COVID-19 Response Mechanism from India's Country Coordinating Mechanism for the purchase of oxygen concentrators and to help finance Pressure Swing Adsorption (PSA) oxygen plants that will help meet the medium-term needs for medical oxygen in the virus-stricken country. In 2020, the fund provided more than $36.8 million through the response mechanism to directly combat the virus and help mitigate its impact on HIV, tuberculosis, and malaria programs globally.
The fund is working with a number of international partners to assist the Indian government as COVID infections and COVID-related deaths exceed three hundred thousand and three thousand per day. In February, a COVID-19 Oxygen Emergency Taskforce was launched by Unitaid and the Wellcome Trust, which are serving as co-leads of the Access to COVID-19 Tools Accelerator (ACT-Accelerator) Therapeutics Pillar, in response to the worsening shortage of oxygen supplies in low- and middle-income countries. In addition to Unitaid and Wellcome, the taskforce brings together key multilateral and development organizations, including WHO, UNICEF, the World Bank, the Clinton Health Access Initiative (CHAI), PATH, the Every Breath Counts coalition, and Save the Children.
(Photo credit: Global Fund/Atul Loke/Panos)